Latest Impairment Charges News

AUCyber Limited reported a 112% revenue increase to $23 million in FY25, driven by acquisitions and cybersecurity growth, despite a $37.6 million net loss largely due to impairment charges. The company’s strategic pivot under 5G Networks’ majority ownership signals a renewed focus on sovereign cloud and AI-enhanced security services.

Dubber Corporation Limited will record a significant non-cash impairment charge in FY25 following the loss of a major customer contract with Virgin Media O2, impacting its intangible assets from a prior acquisition.

Hazer Group Limited reported a 124% surge in revenues to $8.5 million for FY25, driven by government grants, while cutting its net loss by 60%. The company advanced its proprietary methane pyrolysis technology, secured a strategic alliance with KBR, and made progress on key projects in Canada and Japan.

Intelligent Monitoring Group Limited (IMG) reported a 44% revenue surge to $174.9 million in FY25, driven by four key acquisitions and organic growth, while investing heavily in AI-powered video monitoring technology.

Ingenia Communities Group has reported a robust FY25 performance, exceeding underlying EPS guidance with a 33% increase and signalling strong momentum heading into FY26.

Big River Industries reported a modest revenue decline in FY25 but achieved improved margins and operational efficiencies in the second half, positioning itself for growth as market conditions begin to stabilise.

Big River Industries reported a statutory net loss of $14.7 million for FY2025, driven by a $20 million impairment charge on intangible assets amid a 2.3% revenue decline. Despite the setback, the company declared a fully franked 2 cent dividend and showed signs of operational stabilization.

Viva Energy reported a statutory half-year loss of $195.4 million driven by significant retail site impairments and weak refining margins, yet underlying profit on a replacement cost basis remained positive at $62.6 million. The company declared a fully franked interim dividend of 2.83 cents per share, signaling confidence despite operational headwinds.

Noumi Limited reported modest revenue growth and a significant rise in adjusted EBITDA for FY25, driven by its Milklab brand’s strong performance and a continued turnaround in its Dairy & Nutritionals segment. The company also resolved all legacy legal issues, positioning itself for future growth.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.